首页> 外文期刊>Nicotine & Tobacco Research >The Accuracy of Urinary Cotinine Immunoassay Test Strip as an Add-on Test to Self-Reported Smoking Before Major Elective Surgery
【24h】

The Accuracy of Urinary Cotinine Immunoassay Test Strip as an Add-on Test to Self-Reported Smoking Before Major Elective Surgery

机译:尿液可替宁免疫测定试纸作为大选修手术前自我报告吸烟的一项附加测试的准确性

获取原文
获取原文并翻译 | 示例

摘要

Introduction: Smoking is a preventable cause of perioperative complications. An accurate and rapid classification of smoking status is essential as up to 35% of smokers deny smoking before surgery. We compared the diagnostic performance of a preoperative urinary cotinine immunoassay test strip (NicAlert~R) as an add-on test to patient's self-reported smoking status. Methods: Four hundred and sixty-five patients undergoing major elective surgery self-reported their smoking history and provided a sample for measuring urinary cotinine concentration by liquid chromatography tandem mass spectrometry (reference standard) and NicAlert~R. Using the "either test positive" rule, the gain in diagnostic performance for NicAlert~R add-on test was assessed usingrelative positive and negative likelihood ratios (LRs) and area under the receiver operating characteristic curve (AUROC) with 95% CIs. Results: Of the 60 patients with a positive reference standard (adjusted cotinine > 50 ng/ml), 10 (16.7%) denied current cigarette smoking. The NicAlert~R add-on test had better test performance measures (sensitivity = 95.0%, specificity = 94.8%) than self-reported smoking history alone (sensitivity = 83.3%, specificity = 95.0%). The relative positive and negative LRs were 1.09 (95% CI = 0.95-1.24) and 0.30 (95% CI = 0.12-0.78), respectively. The AUROC for the NicAlert~R add-on test (0.90; 95% CI = 0.84-0.96) was significantly higher than for the self-reported smoking history alone (0.78; 95% CI = 0.69-0.88) (p = .006). Conclusion: The NicAlert~R add-on test strategy had excellent diagnostic test performance for identifying current smokers who are expected to have a high risk of perioperative complications.
机译:简介:吸烟是围手术期并发症的可预防原因。准确,快速地分类吸烟状况至关重要,因为多达35%的吸烟者在手术前拒绝吸烟。我们比较了术前尿可替宁免疫测定试纸(NicAlert〜R)作为患者自我报告吸烟状况的附加测试的诊断性能。方法:465例接受大手术的患者自我报告了吸烟史,并提供了通过液相色谱串联质谱法(参考标准)和NicAlert〜R测定尿中可替宁浓度的样品。使用“两个测试均为阳性”规则,使用具有95%CI的相对正负似然比(LR)和接收器工作特性曲线下面积(AUROC)评估NicAlert〜R附加测试的诊断性能增益。结果:60例参考标准为阳性(可替宁> 50 ng / ml)的患者中,有10例(16.7%)拒绝目前吸烟。与仅自我报告的吸烟史(敏感性= 83.3%,特异性= 95.0%)相比,NicAlert〜R附加测试具有更好的测试性能指标(敏感性= 95.0%,特异性= 94.8%)。相对正负LRs分别为1.09(95%CI = 0.95-1.24)和0.30(95%CI = 0.12-0.78)。 NicAlert〜R附加测试的AUROC(0.90; 95%CI = 0.84-0.96)明显高于仅自我报告的吸烟史(0.78; 95%CI = 0.69-0.88)(p = .006 )。结论:NicAlert〜R附加测试策略具有出色的诊断测试性能,可用于识别当前有围手术期并发症高风险的吸烟者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号